Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

CVS Health : 2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)

10/19/2020 | 10:01am EST

Friday, November 13, 2020

Join us as we discuss today’s pressing healthcare issues.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005535/en/

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

CO-HOSTS:

Bunny Ellerin Jing He
Director, HPM, Columbia Business School Biotech Analyst, Gabelli Funds
  • MBA, Harvard Business School
  • MBA, Columbia Business School
  • BA, Columbia University
  • MA, Washington University in St. Louis
  • BS, Peking University
Time Agenda
9:00 – 9:10 AM Welcome
  • Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program
9:10 – 10:00 AM Vaccines & Therapeutics to Treat COVID-19
  • David Hering, Regional President, North America, Pfizer Vaccines
  • Dr. Jacqueline Miller, Senior Vice President, Infectious Diseases, Moderna
  • Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron
  • (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds
10:10 – 11:00 AM Health Policy & Reimbursement Trends
  • Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, New York-Presbyterian
  • Melissa Schulman, Senior Vice President of Government Affairs, CVS Health
  • Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health
  • (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds
11:10 – Noon Healthcare Delivery in a Virtual World
  • Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery
  • Jason Gorevic, CEO, Teladoc Health
  • Dr. Julie Silverstein, Divisional President, Oak Street Health
  • (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).


© Business Wire 2020
All news about CVS HEALTH CORPORATION
11/24CVS HEALTH : Leading global vision nonprofit OneSight teams with Aetna to provid..
PU
11/23CVS HEALTH : Names Neela Montgomery President of CVS Pharmacy
DJ
11/23CVS HEALTH : Names Neela Montgomery President of CVS Pharmacy
PR
11/19Walgreens offers 30-minute pickup for online shoppers
RE
11/17Wall Street closes lower as shutdown worries loom
RE
11/17Amazon launches online pharmacy in new contest with drug retail
RE
11/17Stock Futures Edge Down After Dow Hits Record
DJ
11/17S&P, Dow futures retreat as coronavirus cases spike
RE
11/17Stock Futures Edge Down After Dow Hits Record
DJ
11/17Food-Service Distributor Sysco Names New CFO
DJ
More news
Financials (USD)
Sales 2020 268 B - -
Net income 2020 7 500 M - -
Net Debt 2020 55 969 M - -
P/E ratio 2020 12,0x
Yield 2020 2,96%
Capitalization 88 522 M 88 522 M -
EV / Sales 2020 0,54x
EV / Sales 2021 0,48x
Nbr of Employees 290 000
Free-Float 75,4%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 82,46 $
Last Close Price 67,63 $
Spread / Highest target 50,8%
Spread / Average Target 21,9%
Spread / Lowest Target -2,41%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President